ZAGREB, 15 Jan (Hina) - The DMD association on Monday called on the Croatian drug regulator HALMED and Health Minister Vili Beroš to support its efforts to keep the Translarna medicine, the only drug for Duchenne muscular dystrophy (DMD), on the market.
Association urges minister to support its efforts to keep DMD drug on market
Only logged-in users can see full content details